Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Boehringer Ingelheim
McKesson
Baxter
McKinsey

Last Updated: January 27, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Human calcitonin

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Human calcitonin?

Human calcitonin is an investigational drug.

There have been 16 clinical trials for Human calcitonin. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2018.

The most common disease conditions in clinical trials are Osteoporosis, Diabetes Mellitus, and Migraine Disorders. The leading clinical trial sponsors are Novartis, Amgen, and Health Science Authority Singapore.

There are ninety-one US patents protecting this investigational drug and nine hundred and sixty-seven international patents.

Recent Clinical Trials for Human calcitonin
TitleSponsorPhase
Alendronate Versus Denosumab in Kidney Transplant PatientsNahda UniversityPhase 2/Phase 3
Alendronate Versus Denosumab in Kidney Transplant PatientsAin Shams UniversityPhase 2/Phase 3
Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine.NovartisPhase 4

See all Human calcitonin clinical trials

Clinical Trial Summary for Human calcitonin

Top disease conditions for Human calcitonin
Top clinical trial sponsors for Human calcitonin

See all Human calcitonin clinical trials

US Patents for Human calcitonin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Human calcitonin   Start Trial Anti-CGRP compositions and use thereof ALDERBIO HOLDINGS LLC (Las Vegas, NV)   Start Trial
Human calcitonin   Start Trial Methods for the expression of peptides and proteins Numaferm GmbH (Duesseldorf, DE)   Start Trial
Human calcitonin   Start Trial Phenylalkylcarboxylic acid delivery agents EMISPHERE TECHNOLOGIES, INC. (Roseland, NJ)   Start Trial
Human calcitonin   Start Trial Cloning vector, molecules of recombinant DNA, bacillus subtilis strains transformed with the said molecules and methods for the expression of heterologous genes and the production and secretion of proteins coded by the said genes Eniricerche S.p.A. (Milan, IT)   Start Trial
Human calcitonin   Start Trial Synthetic calcitonin peptides Vical, Inc. (San Diego, CA)   Start Trial
Human calcitonin   Start Trial Calcitonin gene-related peptides for treating erectile dysfunctions   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Human calcitonin

Drugname Country Document Number Estimated Expiration Related US Patent
Human calcitonin Argentina 086515 2031-05-20   Start Trial
Human calcitonin Argentina 086516 2031-05-20   Start Trial
Human calcitonin Argentina 087612 2031-05-20   Start Trial
Human calcitonin Australia 2011336470 2030-12-01   Start Trial
Human calcitonin Australia 2012258966 2030-12-01   Start Trial
Human calcitonin Australia 2012258976 2030-12-01   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Express Scripts
AstraZeneca
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.